Production of glycosylphosphatidylinositol-anchored proteins for vaccines and directed binding of immunoliposomes to specific cell types.

Wesley L Fotoran, Nicole Kleiber, Thomas Müntefering, Eva Liebau, Gerhard Wunderlich
{"title":"Production of glycosylphosphatidylinositol-anchored proteins for vaccines and directed binding of immunoliposomes to specific cell types.","authors":"Wesley L Fotoran, Nicole Kleiber, Thomas Müntefering, Eva Liebau, Gerhard Wunderlich","doi":"10.1590/1678-9199-JVATITD-2020-0032","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Liposomes are highly useful carriers for delivering drugs or antigens. The association of glycosylphosphatidylinositol (GPI)-anchored proteins to liposomes potentially enhances the immunogenic effect of vaccine antigens by increasing their surface concentration. Furthermore, the introduction of a universal immunoglobulin-binding domain can make liposomes targetable to virtually any desired receptor for which antibodies exist.</p><p><strong>Methods: </strong>We developed a system for the production of recombinant proteins with GPI anchors and histidine tags and Strep-tags for simplified purification from cells. This system was applied to i) the green fluorescent protein (GFP) as a reporter, ii) the promising <i>Plasmodium falciparum</i> vaccine antigen PfRH5 and iii) a doubled immunoglobulin Fc-binding domain termed ZZ from protein A of <i>Staphylococcus aureus</i>. As the GPI-attachment domain, the C-terminus of murine CD14 was used. After the recovery of these three recombinant proteins from Chinese hamster ovary (CHO) cells and association with liposomes, their vaccine potential and ability to target the CD4 receptor on lymphocytes in <i>ex vivo</i> conditions were tested.</p><p><strong>Results: </strong>Upon immunization in mice, the PfRH5-GPI-loaded liposomes generated antibody titers of 10<sup>3</sup> to 10<sup>4</sup>, and showed a 45% inhibitory effect on <i>in vitro</i> growth at an IgG concentration of 600 µg/mL in <i>P. falciparum</i> cultures. Using GPI-anchored ZZ to couple anti-CD4 antibodies to liposomes, we created immunoliposomes with a binding efficiency of 75% to CD4<sup>+</sup> cells in splenocytes and minimal off-target binding.</p><p><strong>Conclusions: </strong>Proteins are very effectively associated with liposomes via a GPI-anchor to form proteoliposome particles and these are useful for a variety of applications including vaccines and antibody-mediated targeting of liposomes. Importantly, the CHO-cell and GPI-tagged produced PfRH5 elicited invasion-blocking antibodies qualitatively comparable to other approaches.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"26 ","pages":"e20200032"},"PeriodicalIF":1.8000,"publicationDate":"2020-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Venomous Animals and Toxins Including Tropical Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1678-9199-JVATITD-2020-0032","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Liposomes are highly useful carriers for delivering drugs or antigens. The association of glycosylphosphatidylinositol (GPI)-anchored proteins to liposomes potentially enhances the immunogenic effect of vaccine antigens by increasing their surface concentration. Furthermore, the introduction of a universal immunoglobulin-binding domain can make liposomes targetable to virtually any desired receptor for which antibodies exist.

Methods: We developed a system for the production of recombinant proteins with GPI anchors and histidine tags and Strep-tags for simplified purification from cells. This system was applied to i) the green fluorescent protein (GFP) as a reporter, ii) the promising Plasmodium falciparum vaccine antigen PfRH5 and iii) a doubled immunoglobulin Fc-binding domain termed ZZ from protein A of Staphylococcus aureus. As the GPI-attachment domain, the C-terminus of murine CD14 was used. After the recovery of these three recombinant proteins from Chinese hamster ovary (CHO) cells and association with liposomes, their vaccine potential and ability to target the CD4 receptor on lymphocytes in ex vivo conditions were tested.

Results: Upon immunization in mice, the PfRH5-GPI-loaded liposomes generated antibody titers of 103 to 104, and showed a 45% inhibitory effect on in vitro growth at an IgG concentration of 600 µg/mL in P. falciparum cultures. Using GPI-anchored ZZ to couple anti-CD4 antibodies to liposomes, we created immunoliposomes with a binding efficiency of 75% to CD4+ cells in splenocytes and minimal off-target binding.

Conclusions: Proteins are very effectively associated with liposomes via a GPI-anchor to form proteoliposome particles and these are useful for a variety of applications including vaccines and antibody-mediated targeting of liposomes. Importantly, the CHO-cell and GPI-tagged produced PfRH5 elicited invasion-blocking antibodies qualitatively comparable to other approaches.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生产用于疫苗的糖基磷脂酰肌醇锚定蛋白,以及免疫脂质体与特定细胞类型的定向结合。
背景:脂质体是输送药物或抗原的非常有用的载体。糖基磷脂酰肌醇(GPI)锚定蛋白与脂质体的结合可提高疫苗抗原的表面浓度,从而增强其免疫原性。此外,引入通用的免疫球蛋白结合域可使脂质体靶向存在抗体的几乎任何所需受体:方法:我们开发了一种系统,用于生产带有 GPI 锚、组氨酸标签和 Strep 标签的重组蛋白,以简化从细胞中的纯化。该系统适用于 i) 作为报告基因的绿色荧光蛋白(GFP),ii) 有前景的恶性疟原虫疫苗抗原 PfRH5,iii) 金黄色葡萄球菌蛋白 A 中被称为 ZZ 的双倍免疫球蛋白 Fc 结合域。作为 GPI 连接域,使用了小鼠 CD14 的 C 端。从中国仓鼠卵巢(CHO)细胞中回收这三种重组蛋白并与脂质体结合后,在体外条件下测试了它们的疫苗潜力和靶向淋巴细胞 CD4 受体的能力:结果:小鼠免疫后,PfRH5-GPI-负载脂质体产生的抗体滴度为 103 至 104,在恶性疟原虫培养物中,IgG 浓度为 600 µg/mL 时,对体外生长有 45% 的抑制作用。利用 GPI-anchored ZZ 将抗 CD4 抗体与脂质体结合,我们制备出的免疫脂质体与脾细胞中 CD4+ 细胞的结合率高达 75%,且脱靶结合率极低:蛋白质通过 GPI-anchor 与脂质体非常有效地结合,形成蛋白脂质体颗粒,这些颗粒可用于疫苗和抗体介导的脂质体靶向等多种应用。重要的是,CHO 细胞和 GPI 标记的 PfRH5 所产生的入侵阻断抗体的质量与其他方法相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.80
自引率
8.30%
发文量
39
审稿时长
6-12 weeks
期刊介绍: Journal of Venomous Animals and Toxins including Tropical Diseases (JVATiTD) is a non-commercial academic open access publication dedicated to research on all aspects of toxinology, venomous animals and tropical diseases. Its interdisciplinary content includes original scientific articles covering research on toxins derived from animals, plants and microorganisms. Topics of interest include, but are not limited to:systematics and morphology of venomous animals;physiology, biochemistry, pharmacology and immunology of toxins;epidemiology, clinical aspects and treatment of envenoming by different animals, plants and microorganisms;development and evaluation of antivenoms and toxin-derivative products;epidemiology, clinical aspects and treatment of tropical diseases (caused by virus, bacteria, algae, fungi and parasites) including the neglected tropical diseases (NTDs) defined by the World Health Organization.
期刊最新文献
Isolation and cDNA cloning of four peptide toxins from the sea anemone Heteractis aurora. Human visceral leishmaniasis and polymorphisms in interleukin-coding genes: a systematic review. Prevalence of elephantiasis, an overlooked disease in Southern Africa: a comprehensive review. Snake venom bioprospecting as an approach to finding potential anti-glioblastoma molecules. Immunomodulatory effect of Tityus sp. in mononuclear cells extracted from the blood of rheumatoid arthritis patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1